Tekla Capital Management’s Oruka Therapeutics ORKA Stock Holding History

Tekla Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$65.9K	Hold	2,705	–	–	﹤0.01%	160
2023 Q1	$64.6K	Hold	2,705	–	–	﹤0.01%	172
2022 Q4	$76.6K	Hold	2,705	–	–	﹤0.01%	166
2022 Q3	$67K	Hold	2,705	–	–	﹤0.01%	161
2022 Q2	$81K	Hold	2,705	–	–	﹤0.01%	172
2022 Q1	$75K	Hold	2,705	–	–	﹤0.01%	172
2021 Q4	$70K	Hold	2,705	–	–	﹤0.01%	169
2021 Q3	$96K	Hold	2,705	–	–	﹤0.01%	171
2021 Q2	$113K	Hold	2,705	–	–	﹤0.01%	187
2021 Q1	$118K	Hold	2,705	–	–	﹤0.01%	194
2020 Q4	$130K	Hold	2,705	–	–	﹤0.01%	197
2020 Q3	$143K	Hold	2,705	–	–	0.01%	199
2020 Q2	$215K	Sell	2,705 -301	-10%	-$19.7K	0.01%	217
2020 Q1	$100K	Hold	3,006	–	–	﹤0.01%	210
2019 Q4	$206K	Hold	3,006	–	–	0.01%	205
2019 Q3	$192K	Hold	3,006	–	–	0.01%	182
2019 Q2	$264K	Sell	3,006 -750	-20%	-$67.3K	0.01%	191
2019 Q1	$303K	Hold	3,756	–	–	0.01%	187
2018 Q4	$271K	Hold	3,756	–	–	0.01%	197
2018 Q3	$454K	Hold	3,756	–	–	0.02%	199
2018 Q2	$451K	Hold	3,756	–	–	0.02%	169
2018 Q1	$405K	Hold	3,756	–	–	0.02%	177
2017 Q4	$1.11M	Hold	3,756	–	–	0.04%	144
2017 Q3	$892K	Hold	3,756	–	–	0.03%	138
2017 Q2	$1.99M	Hold	3,756	–	–	0.07%	111
2017 Q1	$2.03M	Hold	3,756	–	–	0.08%	113
2016 Q4	$2.31M	Hold	3,756	–	–	0.1%	99
2016 Q3	$2.34M	Hold	3,756	–	–	0.09%	114
2016 Q2	$2.35M	Hold	3,756	–	–	0.1%	124
2016 Q1	$2.78M	Hold	3,756	–	–	0.12%	107
2015 Q4	$3.77M	Hold	3,756	–	–	0.14%	99
2015 Q3	$4.03M	Buy	+3,756	New	+$5.72M	0.14%	109

Other funds holding ORKA

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tekla Capital Management's ORKA Position: Q2 2023 in Review

Tekla Capital Management held its Oruka Therapeutics (ORKA) position steady in Q2 2023 at 2,705 shares worth $65.9K. The position accounts for ﹤0.01% of the portfolio, ranked #160.

Tekla Capital Management first reported a position in ORKA in Q3 2015 and has held it in 32 quarters since. The position peaked at $4.03M in Q3 2015. 23 funds tracked by Wall St. Rank hold ORKA as of Q2 2023.

Tekla Capital Management held 2,705 shares of Oruka Therapeutics worth $65.9K as of Q2 2023.
Tekla Capital Management left its Oruka Therapeutics share count unchanged in Q2 2023.
Oruka Therapeutics made up ﹤0.01% of Tekla Capital Management's portfolio in Q2 2023, its #160 holding.
Tekla Capital Management first reported a position in Oruka Therapeutics in Q3 2015 and has held it in 32 quarters since.
Tekla Capital Management's Oruka Therapeutics position peaked at $4.03M in Q3 2015.
23 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.